Royal College of Surgeons researchers make progress with drug to fight against sepsis

Research into a new drug therapy to fight sepsis has shown that it has the potential to stop sepsis-causing bacteria from triggering organ damage in the early stages of the condition.

The pre-clinical trial of the drug InnovoSep, carried out by researchers at Royal College of Surgeons in Ireland (RCSI) has demonstrated that the drug also has the potential to stop the progression of sepsis to multiple organ failure in the later stages.